logo
Select company
Select metric
233.77Enterprise Value over EBIT
VS
Market
3
Sector
5
Industry
2
History
-
$ 1.29Close
$ 1.06 - $ 2.55 52-Week Range
Ticker Information

Ticker

HRTX

Company Name

HERON THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

HERON THERAPEUTICS INC - Enterprise Value over EBIT Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

HRTX - EV/EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)Enterprise ValueEnterprise Value over EBIT
6/30/2025$ 1.55M$ 362.57M233.77
3/31/2025$ -5.3M$ 527.19M0
12/31/2024$ -11.1M$ 464.24M0
9/30/2024$ -27.46M$ 347.19M0
6/30/2024$ -47.62M$ 565.28M0
3/31/2024$ -80.45M$ 591.1M0
12/31/2023$ -110.06M$ 505.73M0
9/30/2023$ -118.87M$ 226.18M0
6/30/2023$ -135.77M$ 355.21M0
3/31/2023$ -150.07M$ 396.8M0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • HERON THERAPEUTICS INC's latest trailing twelve months (TTM) EV/EBIT stands at 0.
  • Over the past 5 years, HERON THERAPEUTICS INC's average EV/EBIT has been 233.77.
  • The median EV/EBIT for HERON THERAPEUTICS INC during this period was 233.77
  • HERON THERAPEUTICS INC reached its highest EV/EBIT over the past 5 years at 233.77.
  • The lowest EV/EBIT recorded by HERON THERAPEUTICS INC in the same timeframe 233.77

HERON THERAPEUTICS INC's EV/EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EV/EBIT Benchmarks
CompanyEV/EBIT
GLUE : MONTE ROSA THERAPEUTICS INC 8.02CHRS : COHERUS ONCOLOGY INC -TRDA : ENTRADA THERAPEUTICS INC -MGNX : MACROGENICS INC -VNDA : VANDA PHARMACEUTICALS INC -AGEN : AGENUS INC -IGMS : IGM BIOSCIENCES INC -OSUR : ORASURE TECHNOLOGIES INC -ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC -ALEC : ALECTOR INC -

Definition of Enterprise Value over EBIT

[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
EV / EBIT
(=) EV/EBIT
EV/EBIT for HERON THERAPEUTICS INC is calculated as follows: EV [ $ 1.5B ] / EBIT [ $ -228.7M ]
(=) EV/EBIT [ 0 ]

HRTX - Enterprise Value over EBIT, Last 5 years

233.77

Minimum

Jun 30, 2025

233.77

Maximum

Jun 30, 2025

233.77

Average

233.77

Median

EV/EBIT Benchmark Analysis

The chart above depicts the distribution of EV/EBIT for companies in the Total Stock Market. The average EV/EBIT of the companies is 19.91 with a standard deviation of 12.32.
The following table provides additional summary stats:
EV/EBIT in the Market:
filtered constituents2.25K
min0.05
max62.03
average19.91
median16.78
std12.32